C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 76 filers reported holding C4 THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $34,741 | -99.2% | 11,081 | -98.5% | 0.00% | -100.0% |
| Q4 2022 | $4,357,879 | -39.4% | 738,629 | -54.9% | 0.00% | -40.0% |
| Q3 2022 | $7,188,181 | +12.2% | 1,637,494 | +92.7% | 0.01% | +25.0% |
| Q2 2022 | $6,406,000 | -75.7% | 849,600 | -21.8% | 0.00% | -69.2% |
| Q1 2022 | $26,368,000 | -21.7% | 1,086,782 | +3.9% | 0.01% | -7.1% |
| Q4 2021 | $33,682,000 | -28.1% | 1,045,945 | -0.3% | 0.01% | -30.0% |
| Q3 2021 | $46,867,000 | +9.3% | 1,048,888 | -7.4% | 0.02% | +11.1% |
| Q2 2021 | $42,883,000 | -7.7% | 1,133,129 | -12.5% | 0.02% | -14.3% |
| Q1 2021 | $46,462,000 | +15.1% | 1,295,590 | -0.2% | 0.02% | +10.5% |
| Q4 2020 | $40,370,000 | – | 1,297,609 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $15,939,000 | 8.67% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $54,406,000 | 3.42% |
| Darwin Global Management, Ltd. | 228,595 | $7,573,000 | 2.11% |
| Asymmetry Capital Management, L.P. | 139,343 | $4,616,000 | 2.10% |
| Cormorant Asset Management, LP | 2,490,065 | $80,021,000 | 1.90% |
| Logos Global Management LP | 477,928 | $15,834,000 | 1.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 443,824 | $14,601,000 | 1.30% |
| Soleus Capital Management, L.P. | 268,548 | $8,897,000 | 1.17% |
| P.A.W. CAPITAL CORP | 40,000 | $1,325,000 | 1.17% |
| RTW INVESTMENTS, LP | 2,149,228 | $68,679,000 | 1.15% |